Cite
HARVARD Citation
Coward, J. et al. (n.d.). 1034PPhase I study of intraperitoneal TRX-E-002-1 in subjects with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer: Three-month follow-up results of the dose escalation phase. Annals of oncology. p. . [Online].